Harvard Bioscience (HBIO) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.41% |
| Dec 31, 2025 | -17.34% |
| Sep 30, 2025 | -3.22% |
| Jun 30, 2025 | 4.99% |
| Mar 31, 2025 | -1.22% |
| Dec 31, 2024 | -4.39% |
| Sep 30, 2024 | -21.19% |
| Jun 30, 2024 | -45.02% |
| Mar 31, 2024 | -16.50% |
| Dec 31, 2023 | 6.81% |
| Sep 30, 2023 | 34.80% |
| Jun 30, 2023 | 21.72% |
| Mar 31, 2023 | 106.21% |
| Dec 31, 2022 | 32.74% |
| Sep 30, 2022 | -35.75% |
| Jun 30, 2022 | -36.15% |
| Mar 31, 2022 | -24.91% |
| Dec 31, 2021 | -15.54% |
| Sep 30, 2021 | -20.48% |
| Jun 30, 2021 | -18.31% |
| Mar 31, 2021 | 24.20% |
| Dec 31, 2020 | -19.15% |
| Sep 30, 2020 | 27.76% |
| Jun 30, 2020 | 21.61% |
| Mar 31, 2020 | 36.90% |
| Dec 31, 2019 | -2.71% |
| Sep 30, 2019 | 20.97% |
| Jun 30, 2019 | -27.45% |
| Mar 31, 2019 | 6.64% |
| Dec 31, 2018 | 6.99% |
| Sep 30, 2018 | -23.51% |
| Jun 30, 2018 | 1.88% |
| Mar 31, 2018 | -15.42% |
| Dec 31, 2017 | -20.77% |
| Sep 30, 2017 | -9.08% |
| Jun 30, 2017 | -39.29% |
| Mar 31, 2017 | -19.38% |
| Dec 31, 2016 | 6.43% |
| Sep 30, 2016 | 7.20% |
| Jun 30, 2016 | -5.71% |
| Mar 31, 2016 | -20.91% |
| Dec 31, 2015 | 9.41% |
| Sep 30, 2015 | -18.75% |